We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

61 hedge funds and large institutions have $198M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $790K

Holders
61
Holders Change
+61
Holders Change %
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
61
Increased
Reduced
Closed
Calls
$1.57M
Puts
$790K
Net Calls
+$778K
Net Calls Change
+$778K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

RPTP Hedge Fund Activity: Q2 2013 in Review

61 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q2 2013, worth a combined $198M.

Buyers outnumbered sellers: 61 funds opened new RPTP positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.

  • 61 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $198M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q2 2013.
  • 61 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +61 holders.

Based on aggregated 13F filings for Q2 2013.